(2S)-5-氧代吡咯烷-2-羧酸十二烷基酯 | 75444-31-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: (2S)-5-氧代吡咯烷-2-羧酸十二烷基酯
• 中文别名: 2-氯-N-[2-(1,1-二甲基乙氧基)-2-(4-甲氧苯基)乙基]-3,4-二甲氧基苯乙基胺
• 英文名称: 5-Pyrrolidon-(2)-carbonsaeuredodecylester
• 英文别名: 2-pyrrolidone-5-carboxylic acid n-dodecyl ester；lauryl pyroglutamate；lauryl pyrrolidone-5-carboxylate；Dodecyl 5-oxo-DL-prolinate；dodecyl 5-oxopyrrolidine-2-carboxylate
• CAS: 75444-31-4
• 化学式: C₁₇H₃₁NO₃
• 分子量: 297.438
• InChiKey: HJXPPCPJEYUQFQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  21
• 可旋转键数：
  13
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  55.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (2S)-5-氧代吡咯烷-2-羧酸十二烷基酯 、 碘甲烷 以64%的产率得到
  参考文献：
  名称：

  ABE, YOKO;ITOH, YOSHIAKI

  摘要：

  DOI：
• 作为产物：
  描述：

  十二烷醇 、 DL-焦谷氨酸 、 5-氧代吡咯烷-2-羧酸乙酯 在 Novozym 435 作用下， 60.0 ℃ 、2.0 kPa 条件下， 反应 24.0h， 以100%的产率得到(2S)-5-氧代吡咯烷-2-羧酸十二烷基酯
  参考文献：
  名称：

  Process for the enzymatic synthesis of pyroglutamic esters

  摘要：

  根据通式(I)的一般公式制备化合物的方法，其中R是醇的烃基，其中通式(II)R—OH的一个或多个醇在不使用大量溶剂的情况下酯化和/或酯交换，最好是无溶剂，最好在低于100°C的温度下在减压条件下，在水解酶类酶的存在下与通式(III)的化合物一起提供，其中R1是氢或具有1到3个碳原子的直链或支链烷基或烯烃基。

  公开号：

  US20060074259A1

文献信息

• Additives and products including oligoesters
  申请人：——

  公开号：US20030199593A1

  公开（公告）日：2003-10-23

  The present invention relates to oligoesters and their use or the creation of additives. Oligoester containing additives and/or oligoesters themselves may be used for formulating pharmaceutical preparations, cosmetics or personal care products such as shampoos and conditioners. These oligoesters are particularly useful for the creation of multi-purpose additives that can impart conditioning, long substantivity and/or UV protection. Individual oligoesters and oligoester mixtures are described.

  本发明涉及寡酯及其用途或添加剂的制备。含有寡酯的添加剂和/或寡酯本身可用于配制药物制剂、化妆品或个人护理产品，如洗发水和护发素。这些寡酯对于制备能够赋予调理、长效性和/或紫外线保护的多功能添加剂特别有用。描述了单独的寡酯和寡酯混合物。
• [EN] PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES<br/>[FR] COMPOSITIONS PHARMACEUTIQUES COMPRENANT DES MONOTERPÈNES
  申请人：NEONC TECHNOLOGIES INC

  公开号：WO2011109635A1

  公开（公告）日：2011-09-09

  The present invention provides a process for purifying a monoterpene or sesquiterpene having a purity greater than about 98.5% (w/w) The process comprises the steps of derivatizing the monoterpene (or sesquiterpene) to produce a monoterpene (or sesquiterpene) derivative, separating the monoterpene (or sesquiterpene) derivative, and releasing the monoterpene (or sesquiterpene) from the derivative Also encompassed by the scope of the present invention is a pharmaceutical composition comprising a monoterpene (or sesquiterpene) having a purity greater than about 98.5% (w/w) The purified monoterpene can be used to treat a disease such as cancer The present monoterpene (or sesquiterpene) may be administered alone, or may be co-administered with radiation or other therapeutic agents, such as chemotherapeutic agents.

  本发明提供了一种用于纯化纯度大约高于98.5%（质量百分比）的单萜或倍半萜的过程。该过程包括将单萜（或倍半萜）衍生化以产生单萜（或倍半萜）衍生物，分离单萜（或倍半萜）衍生物，并从衍生物中释放单萜（或倍半萜）。本发明范围还涵盖了一种含有纯度大约高于98.5%（质量百分比）的单萜（或倍半萜）的药物组合物。纯化的单萜可用于治疗癌症等疾病。目前的单萜（或倍半萜）可以单独使用，也可以与放射线或其他治疗剂（如化疗药物）联合使用。
• Imidazoline quats
  申请人：Croda, Inc.

  公开号：US20040220062A1

  公开（公告）日：2004-11-04

  Mixture of dialkyl imidazoline quats with specified substitution content are provided. In one embodiment, at least a portion of the mixture includes at least one dialkyl imidazoline quat having at least one C 16 -C 30 alkyl group; the C 16-30 substitution content of the mixture being from about 10% to about 95% with respect to C 10+ reference substitution range. Methods of making imidazoline quats and quat mixtures, personal care and cosmetic products and formulations that contain the imidazoline quats and quat mixtures, methods of making such personal care and cosmetic products and formulations, and methods of using the such imidazoline quats, quat mixtures, and personal care and cosmetic products and formulations are also provided. Various embodiments are disclosed.

  提供具有指定取代含量的二烷基咪唑啉季铵盐混合物。在一个实施例中，至少部分混合物包括至少一种具有至少一个C16-C30烷基基团的二烷基咪唑啉季铵盐；混合物的C16-C30取代含量相对于C10+参考取代范围约为10%至95%。还提供制备咪唑啉季铵盐和季铵盐混合物的方法，包含咪唑啉季铵盐和季铵盐混合物的个人护理和化妆品产品和配方，制备这种个人护理和化妆品产品和配方的方法，以及使用这种咪唑啉季铵盐、季铵盐混合物、个人护理和化妆品产品和配方的方法。还披露了各种实施例。
• Compositions containing esters of aromatic alkoxylated alcohols and fatty carboxylic acids
  申请人：——

  公开号：US20030161792A1

  公开（公告）日：2003-08-28

  A personal care or cosmetic product composition that includes from about 0.1% to about 99% of at least one ester of alkoxylated aromatic alcohol and fatty carboxylic acid, and from about 0.1% to 60% of at least one functional ingredient is provided. The functional ingredients in the composition may include active ingredients and additional ingredients. Especially suitable active ingredients are sunscreen active ingredients and antiperspirant active ingredients. Preferred compositions are sunscreen product formulations and antiperspirant products. In one preferred embodiment, the composition further includes at least one cyclomethicone compound present in the amount of from about 1% to 99% by weight of the composition. A method of improving the protection of human or animal skin or hair from radiation and a method of improving the protection of human or animal skin or hair from perspiration are also provided.

  提供一种个人护理或化妆品组合物，包括约0.1%至约99%的至少一种烷氧基芳香醇和脂肪羧酸酯，以及约0.1%至60%的至少一种功能性成分。组合物中的功能性成分可能包括活性成分和额外成分。特别适用的活性成分包括防晒活性成分和止汗活性成分。首选的组合物是防晒产品配方和止汗产品。在一个首选实施例中，该组合物还包括至少一种环硅烷化合物，其占组合物重量的约1%至99%。还提供了一种改善人类或动物皮肤或毛发免受辐射的保护的方法，以及一种改善人类或动物皮肤或毛发免受汗水侵害的方法。
• Transdermal galantamine delivery system
  申请人：Audett Jay

  公开号：US20070104771A1

  公开（公告）日：2007-05-10

  A transdermal galantamine delivery system to an individual. The system has a high galantamine loading with suitable permeation enhancers to effect therapeutic flux rate. Acrylate polymeric reservoir with the high galantamine and permeation enhancers dissolved therein provides desirable adhesive characteristics and effective transdermal therapeutic properties for multiple-day delivery.

  一个透皮的加兰他敏递送系统，适用于个人。该系统具有高加兰他敏负载量，并配有适当的渗透增强剂以实现治疗通量率。丙烯酸酯聚合物储液池中含有高加兰他敏和渗透增强剂，提供理想的粘附特性和有效的透皮治疗属性，可进行多日递送。